96 related articles for article (PubMed ID: 12101568)
1. [Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice].
Alimova IN; Bashurin DA; Popovich IG; Zabezhinskiĭ MA; Volkov MA; Provinciali M; Franceschi C; Khavincon BKh; Anisimov VN
Vopr Onkol; 2002; 48(1):57-60. PubMed ID: 12101568
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Khavinson VK; Provinciali M; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Imyanitov EN; Mancini R; Franceschi C
Int J Cancer; 2002 Sep; 101(1):7-10. PubMed ID: 12209581
[TBL] [Abstract][Full Text] [Related]
3. Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.
Anisimov VN; Khavinsov VKh; Alimova IN; Provintsiali M; Manchini R; Francheski K
Bull Exp Biol Med; 2002 Feb; 133(2):167-70. PubMed ID: 12428286
[TBL] [Abstract][Full Text] [Related]
4. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.
Kossoy G; Anisimov VN; Ben-Hur H; Kossoy N; Zusman I
In Vivo; 2006; 20(2):253-7. PubMed ID: 16634527
[TBL] [Abstract][Full Text] [Related]
5. [Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats].
Pliss GB; Mel'nikov AS; Malinin VV; Khavinson VKh
Vopr Onkol; 2001; 47(5):601-7. PubMed ID: 11785104
[TBL] [Abstract][Full Text] [Related]
6. Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA.
Sfondrini L; Besusso D; Rumio C; Rodolfo M; Ménard S; Balsari A
FASEB J; 2002 Nov; 16(13):1749-54. PubMed ID: 12409317
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats.
Anisimov VN; Khavinson VKh; Popovich IG; Zabezhinski MA
Cancer Lett; 2002 Sep; 183(1):1-8. PubMed ID: 12049808
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
9. Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa.
Kossoy G; Zandbank J; Tendler E; Anisimov V; Khavinson V; Popovich I; Zabezhinski M; Zusman I; Ben-Hur H
Int J Mol Med; 2003 Oct; 12(4):473-7. PubMed ID: 12964022
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
[TBL] [Abstract][Full Text] [Related]
11. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice.
Anisimov VN; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Manton KG; Semenchenko AV; Yashin AI
Int J Cancer; 2003 Jan; 103(3):300-5. PubMed ID: 12471612
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
[TBL] [Abstract][Full Text] [Related]
13. Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Egormin PA; Bershtein LM; Zabezhinskii MA; Piskunova TS; Popovich IG; Semenchenko AV
Bull Exp Biol Med; 2005 Jun; 139(6):721-3. PubMed ID: 16224592
[TBL] [Abstract][Full Text] [Related]
14. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G
Cancer Res; 2000 Jan; 60(2):359-64. PubMed ID: 10667588
[TBL] [Abstract][Full Text] [Related]
15. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM
Cancer Res; 2000 Jul; 60(13):3569-76. PubMed ID: 10910070
[TBL] [Abstract][Full Text] [Related]
17. [Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data].
Khavinson VKh; Kuznik BI; Tarnovskaia SI; Lin'kova NS
Adv Gerontol; 2014; 27(3):399-406. PubMed ID: 25826983
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL
Am J Pathol; 2005 Apr; 166(4):1205-16. PubMed ID: 15793299
[TBL] [Abstract][Full Text] [Related]
19. [Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)].
Anisimov VN; Popovich IG; Zabezhinskiĭ MA; Rozenfel'd SV; Khavinson VKh; Semenchenko AV; Iashin AI
Vopr Onkol; 2005; 51(1):93-8. PubMed ID: 15909815
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
